Why is JHS Sven.Lab. falling/rising?

As of 02-September, JHS Svendgaard Laboratories Ltd's stock price is currently at 11.84, reflecting an increase of 0.78 or 7.05%. The stock has been gaining for the last three days, with a total return of 14.4% during this period, and has outperformed its sector by 5.57%. However, despite this recent uptick, the company has shown significant underperformance over the longer term, with a year-to-date decline of 45.36% and a staggering 60.57% drop over the past year. The stock's fundamentals are concerning, as it has reported negative operating profit growth and a poor EBIT to Interest ratio, indicating weak financial health. Additionally, the company has been generating negative EBITDA and has reported losses, which further complicates its outlook.
In the broader market context, while JHS Svendgaard Laboratories has experienced a positive short-term return, the benchmark Sensex has seen a slight decline of 0.78% over the same one-week period. This contrast highlights the stock's recent ability to rebound in a generally unfavorable market environment. However, the stock's long-term performance remains troubling, as it has consistently underperformed against the benchmark over the last three years, with a return of -54.11% compared to the Sensex's gain of 36.32%. The combination of weak long-term fundamentals and a lack of investor participation, as evidenced by a significant drop in delivery volume, suggests that while there may be short-term gains, the overall outlook for JHS Svendgaard Laboratories Ltd remains precarious.